Your search returned 63 studies. (Get alerts for new studies):
- Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease
Conditions: Graft vs Host Disease - Hematologic Neoplasm
1 Location available
- Chemotherapy and Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Disease or Hematologic Cancer
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
1 Location available
- Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Flu
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult
4 Locations available
- Extracorporeal Photopheresis for Acute Graft Versus Host Disease
Conditions: Graft Versus Host Disease - Cancer - Stem Cell Transplantation
1 Location available
- A Phase II Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease
Conditions: Graft vs Host Disease - Blood and Marrow Transplant (BMT)
1 Location available
- A Study to Lower the Occurrences and Severity of Graft-versus-host Disease
Conditions: Graft vs Host Disease
2 Locations available
- Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant
Conditions: Graft Versus Host Disease - Leukemia
56 Locations available
- Dexamethasone to Prevent Oral Chronic Graft-versus-Host Disease
Conditions: Graft vs Host Disease
1 Location available
- Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms - Secondary Myelofibrosis - Small Intestine Cance
1 Location available
- Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer o
Conditions: Graft Versus Host Disease - Leukemia - Myelodysplastic Syndromes
1 Location available
- Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other Diseases
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Myelodysplastic Syndromes - Secondary Myelofibrosis
1 Location available
- High-Dose Cyclophosphamide in Treating Patients With Acute Graft-Versus-Host Disease That Did Not Respond to Steroid Therapy
Conditions: Graft Versus Host Disease
1 Location available
- Yttrium Y 90 Ibritumomab Tiuxetan, Rituximab, Indium In-111 Ibritumomab Tiuxetan, Fludarabine, Melphalan, and Donor Stem Cell Transplant in Treating P
Conditions: Graft Versus Host Disease - Leukemia - Lymphoma
1 Location available
- Measurements of Resting Energy Expenditure in Patients With or at Risk of Developing Graft Versus Host Disease
Conditions: Graft-Versus-Host Disease
1 Location available
- Photopheresis for the Treatment of Acute Graft Versus Host Disease
Conditions: Graft Versus Host Disease
1 Location available
- Rapamycin for Prevention of Chronic Graft-Versus-Host Disease
Conditions: Graft Versus Host Disease
1 Location available
- Development and Validation of a Symptom Scale for Children With Chronic Graft-Versus-Host Disease
Conditions: Graft vs Host Disease
1 Location available
- Improving Outcomes Assessment in Chronic GVHD
Conditions: Chronic Graft Versus Host Disease
9 Locations available
- Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant
Conditions: Graft Versus Host Disease
1 Location available
- Montelukast to Treat Bronchiolitis Obliterans
Conditions: Bronchiolitis Obliterans - Chronic Graft Versus Host Disease - Leukotriene - Montelukast - Stem Cell Transplant
4 Locations available
- A Study Using Tacrolimus, Sirolimus and Bortezomib as Acute Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Peripheral Blood Stem Cell (PBS
Conditions: Graft vs Host Disease - Peripheral Blood Stem Cell Transplantation - Transplantation, Homologous
1 Location available
- Topical Dexamethasone and Tacrolimus for the Treatment of Oral Chronic Graft-Versus-Host Disease
Conditions: Oral Chronic Graft-versus-host Disease
4 Locations available
- Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor
Conditions: Chronic Myeloproliferative Disorders - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
2 Locations available
- The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host Disease
Conditions: Acute Graft Versus Host Disease
1 Location available
- Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Ca
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
5 Locations available
- Voriconazole Pharmacokinetics in Children With Gastrointestinal Graft Versus Host Disease
Conditions: Graft Versus Host Disease - Stem Cell Transplantation
1 Location available
- Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant
Conditions: Hematologic Malignancies - Graft vs Host Disease
2 Locations available
- Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD
Conditions: Graft Versus Host Disease - Leukemia - Myelodysplastic Syndromes
2 Locations available
- Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer
Conditions: Renal Cell Carcinoma - Graft-Versus-Host Disease - Engraftment Syndrome
2 Locations available
- Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease
Conditions: Graft Versus Host Disease - Recurrent Adult Acute Lymphoblastic Leukemia
2 Locations available
- Rifaximin for Preventing Acute Graft Versus Host Disease (AGVHD)
Conditions: Malignancy - Bone Marrow Transplantation
2 Locations available
- Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Severe Congenital Anemias Including Sickle
Conditions: Peripheral Blood Stem Cell Transplantation - Anemia, Sickle Cell - Graft-Versus-Host Disease - Sirolimus (Rapamune(Registered Trademark)) - Alemtuzumab (Campath(Registered Trademark))
1 Location available
- Safety and Tolerability Trial of Abatacept-based Immunosuppression for Prevention of Acute Graft Versus Host Disease (aGVHD) During Transplant
Conditions: AML - ALL - Undifferentiated Leukemia - Biphenotypic Leukemia - Refractory Anemia - Refractory Anemia With Ringed Sideroblasts - Refractory Cytopenia With Multilineage Dysplasia - Refractory Cytopenia With Multilineage Dysplasia and Ringed Sideroblasts -
2 Locations available
- Rituximab in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer
Conditions: Leukemia, Myeloid, Accelerated Phase - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Nasal Type Extranodal NK/T-cell Lymphoma - Blast Phase - Contiguous Stage II Adult Burkitt's Lymphoma - Contiguous S
1 Location available
- Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)
Conditions: Chronic GVHD
39 Locations available
- Histone Deacetylase Inhibitor LBH589 in Addition to Corticosteroids in Patients With Acute Graft Versus Host Disease
Conditions: Graft-Versus-Host Disease
1 Location available
- Sirolimus, Tacrolimus, Antithymocyte Globulin, and Rituximab in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancers or Other Dis
Conditions: Chronic Myeloproliferative Disorders - Graft Versus Host Disease - Leukemia - Lymphoma - Lymphoproliferative Disorder - Multiple Myeloma and Plasma Cell Neoplasm - Myelodysplastic Syndromes - Myelodysplastic/Myeloproliferative Neoplasms
1 Location available
- Phase 1 Nilotinib in Steroid Dependent/Refractory Chronic Graft Versus Host Disease
Conditions: Blood and Marrow Transplant (BMT) - Lymphomas: Non-Hodgkin - Peripheral T-Cell
2 Locations available
- Rituximab for the Primary Treatment of Denovo Extensive Chronic Graft Versus Host Disease (GVHD)
Conditions: Chronic Graft-versus-host Disease
1 Location available
- Pilot Study: Patients With Chronic Active Graft Versus Host Disease That Have Failed or Not Tolerated Standard Therapy.
Conditions: Blood Stem Cell Transplant Failure - Graft Versus Host Disease
1 Location available
- Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant
Conditions: Stem Cell Leukemia of Unclear Lineage - Graft Versus Host Disease
1 Location available
- Atorvastatin for the Prophylaxis of Acute Graft-versus-host Disease in Patients Undergoing Matched Sibling Allogeneic Transplantation
Conditions: Graft vs Host Disease
1 Location available
- Impact of Adnexal Involvement of the Severity and Prognosis of Chronic Graft-versus-Host Disease
Conditions: Graft vs Host Disease - Chronic Graft vs Host Disease - cGVHD
2 Locations available
- Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transpl
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome - Acute Myeloid Leukemia/Transient Myeloproliferative Disorder - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormali
5 Locations available
- Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities - Adult Acute Myeloid Leukemia With Del(5q) - Adult
1 Location available
- Sirolimus, Cyclosporine, and Mycophenolate Mofetil In Preventing Graft-Versus-Host Disease in Treating Patients With Hematologic Malignancies Undergoi
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome - Acute Myeloid Leukemia/Transient Myeloproliferative Disorder - Adult Acute Lymphoblastic Leukemia in Remission - Adult
2 Locations available
- Exstension Study (Extended Access) of Cyclosporine Inhalation Solution (CIS) in Lung Transplant and Hematopoietic Stem Cell Transplant Recipients for
Conditions: Bronchiolitis Obliterans - Constructive Bronchiolitis - Graft Versus Host Disease
1 Location available
- Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)
Conditions: GVHD - Adult Acute Myeloid Leukemia - Acute Lymphoid Leukemia - Myelodysplastic Syndrome
17 Locations available
- Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease
Conditions: Sclerodermoid Chronic Graft-versus-host Disease - Graft Versus Host Disease in Skin
5 Locations available
- Biomarkers in Predicting Response in Patients With Graft-Versus-Host Disease Undergoing Extracorporeal Photophoresis
Conditions: Graft Versus Host Disease (GVHD)
1 Location available
- Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease
Conditions: Chronic Graft-versus-host Disease
1 Location available
- The Natural History of Graft-Versus-Host Disease in the Eyes
Conditions: Graft-Versus-Host Disease
1 Location available
- A Safety and Efficacy Study of Uvadex and Extracorporeal Photopheresis (ECP) in Chronic Graft Versus Host Disease
Conditions: Chronic Graft Versus Host Disease
8 Locations available
- Factors Determining Outcomes in Patients With Graft-Versus-Host Disease
Conditions: Graft vs Host Disease
1 Location available
- Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematologica
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Megakaryoblastic Leukemia (M7) - Adult Acute Myeloid Leukemia in Remission - Adult Erythroleukemia (M6a) - Adult Nasal Type Extranodal NK/T-cell
1 Location available
- In-vivo Regulatory T Cell Enhancement With Cyclophosphamide and Sirolimus With or Without Vidaza (Azacitidine) for Steroid-refractory Acute Graft-vers
Conditions: Graft Versus Host Disease
1 Location available
- Outcomes of Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With Extracorporeal Photopheresis Treatment
Conditions: Cutaneous T Cell Lymphoma - Graft Versus Host Disease
1 Location available
- Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease
Conditions: Acute Graft Versus Host Disease
1 Location available
- Pharmacokinetics-based Mycophenolate Mofetil Dosing for GVHD Prevention
Conditions: Allogeneic Blood and Marrow Transplantation (BMT) - Graft Versus Host Disease
1 Location available
- Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hemato
Conditions: Acute Myelogenous Leukemia - Acute Lymphocytic Leukemia - Myelodysplastic Syndrome
1 Location available
- Alpha 1 Anti-Trypsin in Treating Patients With Acute Graft-Versus-Host Disease
Conditions: Graft Versus Host Disease
1 Location available
- Exploratory Safety Study of ALD518 in Subjects With Steroid-refractory Acute Graft Versus Host Disease (GVHD)
Conditions: Acute GvHD
5 Locations available
- Clobetasol for Oral Graft-Versus-Host Disease
Conditions: Oral Chronic Graft vs Host Disease
1 Location available
|